Challenges of Regulation and Risk Assessment of Nanomaterials

More documents

Recommendations

Info

51 MROZIEWICZ Kinga Bureau For Chemical Substances and Preparations Poland 52 NORTHFLEET Christina Omya International AG Switzerland 53 PALOSAARI Taina European Commission - JRC - IHCP Italy 54 POLAND Craig Institute of Occupational Medicine (IOM) United Kingdom 55 PONCE DEL CASTILLO 56 POPESCU Laura Madalina Aida European Trade Union Institute (ETUI) National Research and Development Institute for Nonferrous and Rare Metals Belgium Romania 57 PROYKOVA Ana University of Sofia Bulgaria 58 QUINN Bernadette European Chemicals Agency (ECHA) Finland 59 RASMUSSEN Kirsten European Commission - JRC - IHCP Italy 60 RAUSCHER Hubert European Commission - JRC - IHCP Italy 61 RIEDL Alexander European Commission - JRC - IHCP Italy 62 RIEGO SINTES Juan European Commission - JRC - IHCP Italy 63 ROSE Jerome CNRS CEREGE France 64 ROSSI François European Commission - JRC - IHCP Italy 65 SCHROEDER Frauke BAuA Germany 66 SIMION Monica National Institute for R-D in Microtechnologies Romania 67 SKAUG Vidar National Institute of Occupational Health Norway 68 SOKULL- KLUETTGEN Birgit European Commission - JRC - IHCP Italy 69 SPURGEON David Centre for Ecology and Hydrology United Kingdom 70 STAMM Hermann European Commission - JRC - IHCP Italy 71 STINTZ Michael TU Dresden, Inst. Verfahrenstechnik Germany 72 STONE Vicky Heriot-Watt University United Kingdom 73 TOUFEKTSIAN Marie-Claire Observatory for Micro & NanoTechnologies, OMNT (CEA/CNRS) France 74 TRAN Ignace Lang Institute of Occupational Medicine (IOM) 75 VAN TONGEREN Martinus Institute of Occupational Medicine (IOM) United Kingdom United Kingdom 62
76 VOM BROCKE Jochen German Federal Institute for Risk Assessment Germany 77 VAZQUEZ- CAMPOS Socorro LEITAT Technological Centre Spain 78 VEGRO Stefania European Commission - JRC - IHCP Italy 79 WIKSTAD Emma Swedish Chemicals Agency Sweden 63
Page 1 and 2:
Challenges of Regulation and Risk A
Page 3 and 4:
TABLE OF CONTENTS 1. INTRODUCTION .
Page 5 and 6:
2. REGULATORY DEVELOPMENTS 2.1. Sum
Page 7 and 8:
into risk assessments and risk mana
Page 9 and 10:
Nanomaterials in the Regulatory Dev
Page 11 and 12: Guidance on the risk assessment of
Page 13 and 14: Current Progress of activity and ef
Page 15 and 16: of the Sponsorship programme and pr
Page 17 and 18: exposure using new metrics and to d
Page 19 and 20: and risks would increase the probab
Page 21 and 22: OECD Working Party on Manufactured
Page 23 and 24: REACH Implementation Project on Nan
Page 25 and 26: Industry experience with conducting
Page 27 and 28: Health, Safety, and Environment: As
Page 29 and 30: 4. CHARACTERISATION AND DETECTION O
Page 31 and 32: 4.2. Abstracts 31
Page 33 and 34: Primary and secondary characterizat
Page 35 and 36: 5. EXPOSURE ASSESSMENT 5.1. Summary
Page 39 and 40: Application and adaptation of expos
Page 41 and 42: areas. The final remark was that th
Page 45 and 46: Integrating test strategy for ecoto
Page 47 and 48: Ageing and Toxicity of real NM in a
Page 49 and 50: The bioavailability and trophic tra
Page 51 and 52: 7. HUMAN TOXICITY 7.1. Summary reco
Page 55 and 56: Variation in acute toxicity for 9 e
Page 57 and 58: In conclusion, the in vitro hepatoc
Page 59 and 60: Acknowledgements The editors would
Page 61: 24 FURUNO Shoko Association (NIA) A
Page 65 and 66: 05. NANEX: development of Exposure
Page 68 and 69: European Commission JRC 67654- Join
Page 70: The mission of the JRC is to provid
show all

Challenges of Regulation and Risk Assessment of Nanomaterials

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?